Likewise, administration of siRNA targeting VNN1 to mice fed with a methionine- and choline-deficient diet protected against NASH-induced pathological angiogenesis in the liver. The gene discussed is VNN1; the disease is metabolic dysfunction-associated steatohepatitis.